Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising cases of animal bites
3.2.1.2 Increasing prevalence of neglected tropical diseases (NTDS)
3.2.1.3 Technological advancements in diagnostics
3.2.1.4 Favorable government policies
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of test
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
3.8 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Test Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Fluorescent antibody test (FAT)
5.3 Immunohistochemical test
5.4 Amplification methods
5.5 Histologic examination
5.6 Serology tests
Chapter 6 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 ELISA
6.3 Chromatography
6.4 PCR
6.5 Other techniques
Chapter 7 Market Estimates and Forecast, By Sample Type, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Brain tissue
7.3 Saliva
7.4 Cerebrospinal fluid (CSF)
7.5 Blood (Serum)
7.6 Other sample types
Chapter 8 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals and clinics
8.3 Diagnostic laboratories
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Netherlands
9.3.7 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Abbexa Ltd
10.2 Aviva Systems Biology Corporation
10.3 BIONOTE Co., LTD
10.4 Bio-Rad Laboratories, Inc.
10.5 Creative Diagnostics
10.6 Demeditec Diagnostics GmbH
10.7 Merck KGaA
10.8 MyBioSource, Inc.
10.9 Norgen Biotek Corp.
10.10 Thermo Fisher Scientific Inc.
